Corpus Intelligence IC Memo — JACKSON-MADISON COUNTY GENERAL HOSP 2026-04-26 03:43 UTC
IC Memo — JACKSON-MADISON COUNTY GENERAL HOSP
Investment Committee Memorandum | TN | 580 beds | Grade B | EBITDA uplift $58.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

JACKSON-MADISON COUNTY GENERAL HOSP

CCN 440002 | MADISON, TN | 580 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

JACKSON-MADISON COUNTY GENERAL HOSP is a 580-bed suburban community hospital in MADISON, TN with $797.1M in net patient revenue and a 1.4% operating margin. The hospital serves a payer mix of 29.0% Medicare, 2.1% Medicaid, and 69.0% commercial.

Thesis: Undervalued. Our ML models identify $58.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.4% to 8.7% (+736bps).

Net Revenue HCRIS$797.1M
Current EBITDA COMPUTED$11.0M
Operating Margin COMPUTED1.4%
Occupancy HCRIS75.1%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS28.0%
Distress Probability ML43.0%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
16
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 1.4% places it above the state median. Among 16 size-comparable peers (290-1160 beds), the median margin is -7.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (290-1160), prioritizing same-state peers. 16 hospitals in the comp set.

HospitalStateBedsRevenueMargin
JACKSON-MADISON COUNTY GENERAL (Target)TN580$797.1M1.4%
VANDERBILT UNIVERSITY MEDICAL TN1084$5.44B-15.9%
ERLANGER MEDICAL CENTERTN750$1.09B-6.4%
UNIVERSITY OF TENNESSEE MEDICATN698$1.08B-17.6%
SAINT THOMAS WEST HOSPITALTN643$1.06B0.2%
TRISTAR CENTENNIAL MEDICAL CENTN598$991.8M23.0%
BAPTIST MEM HOSPITAL MEMPHISTN800$766.1M-12.7%
MEMORIAL HEALTH CARE SYSTEM INTN431$583.9M-9.0%
JOHNSON CITY MEDICAL CENTERTN537$546.1M-8.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $58.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$16.7M+210bp18mo
Cost to Collect4.5%2.5%$15.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$15.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$9.7M+122bp9mo
Clean Claim Rate88.0%96.0%$510K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$16.7M
Cost to Collect
$15.9M
Denial Rate Reduction
$15.8M
A/R Days Reduction
$9.7M
Clean Claim Rate
$510K
Total EBITDA Uplift$58.7M
Current EBITDA$11.0M
+ RCM Uplift+$58.7M
Pro Forma EBITDA$69.7M
Current Margin1.4%
Pro Forma Margin8.7%
WC Released (1x)$30.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$16.9M$659.3M38.98x108.1%
Base (11x exit)10.0x11.0x$16.9M$730.7M43.21x112.4%
Bull Case9.0x11.0x$15.2M$929.8M61.09x127.6%
Bull (12x exit)9.0x12.0x$15.2M$1.02B66.94x131.8%
Bear Case11.0x10.0x$18.6M$360.4M19.37x80.9%
Bear (11x exit)11.0x11.0x$18.6M$402.5M21.64x84.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 16 hospitals with 290-1160 beds
  • Same-state prioritization (n=17)
  • Comp margins: P25=-12.8% / P50=-7.5% / P75=4.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.